315 related articles for article (PubMed ID: 38819836)
1. Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development.
Khalaji A; Mehrtabar S; Jabraeilipour A; Doustar N; Rahmani Youshanlouei H; Tahavvori A; Fattahi P; Alavi SMA; Taha SR; Fazlollahpour-Naghibi A; Shariat Zadeh M
Ther Adv Cardiovasc Dis; 2024; 18():17539447241253134. PubMed ID: 38819836
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology.
Chawra HS; Agarwal M; Mishra A; Chandel SS; Singh RP; Dubey G; Kukreti N; Singh M
Pathol Res Pract; 2024 Feb; 254():155091. PubMed ID: 38194804
[TBL] [Abstract][Full Text] [Related]
3. Roles of MicroRNA-122 in Cardiovascular Fibrosis and Related Diseases.
Liu Y; Song JW; Lin JY; Miao R; Zhong JC
Cardiovasc Toxicol; 2020 Oct; 20(5):463-473. PubMed ID: 32856216
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-101a suppresses fibrotic programming in isolated cardiac fibroblasts and in vivo fibrosis following trans-aortic constriction.
Zhou Y; Shiok TC; Richards AM; Wang P
J Mol Cell Cardiol; 2018 Aug; 121():266-276. PubMed ID: 30053527
[TBL] [Abstract][Full Text] [Related]
5. miR-22 in cardiac remodeling and disease.
Huang ZP; Wang DZ
Trends Cardiovasc Med; 2014 Oct; 24(7):267-72. PubMed ID: 25218673
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13.
Zhou Y; Deng L; Zhao D; Chen L; Yao Z; Guo X; Liu X; Lv L; Leng B; Xu W; Qiao G; Shan H
J Cell Mol Med; 2016 Mar; 20(3):495-505. PubMed ID: 26756969
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of microRNA-23b prevents polymicrobial sepsis-induced cardiac dysfunction by modulating TGIF1 and PTEN.
Zhang H; Caudle Y; Shaikh A; Yao B; Yin D
Biomed Pharmacother; 2018 Jul; 103():869-878. PubMed ID: 29710503
[TBL] [Abstract][Full Text] [Related]
8. Endothelial-to-Mesenchymal Transition: Role in Cardiac Fibrosis.
Cheng W; Li X; Liu D; Cui C; Wang X
J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):3-11. PubMed ID: 32851865
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-101a inhibits cardiac fibrosis induced by hypoxia via targeting TGFβRI on cardiac fibroblasts.
Zhao X; Wang K; Liao Y; Zeng Q; Li Y; Hu F; Liu Y; Meng K; Qian C; Zhang Q; Guan H; Feng K; Zhou Y; Du Y; Chen Z
Cell Physiol Biochem; 2015; 35(1):213-26. PubMed ID: 25591764
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-323a-3p Promotes Pressure Overload-Induced Cardiac Fibrosis by Targeting TIMP3.
Zhang J; Lang Y; Guo L; Pei Y; Hao S; Liang Z; Su G; Shu L; Liu H; Huang C; Xu J
Cell Physiol Biochem; 2018; 50(6):2176-2187. PubMed ID: 30415251
[TBL] [Abstract][Full Text] [Related]
11. The Impact of microRNAs in Renin-Angiotensin-System-Induced Cardiac Remodelling.
Adamcova M; Kawano I; Simko F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946230
[TBL] [Abstract][Full Text] [Related]
12. Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction.
Cheng M; Wu G; Song Y; Wang L; Tu L; Zhang L; Zhang C
Cell Physiol Biochem; 2016; 38(5):1928-38. PubMed ID: 27160852
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21-Dependent Macrophage-to-Fibroblast Signaling Determines the Cardiac Response to Pressure Overload.
Ramanujam D; Schön AP; Beck C; Vaccarello P; Felician G; Dueck A; Esfandyari D; Meister G; Meitinger T; Schulz C; Engelhardt S
Circulation; 2021 Apr; 143(15):1513-1525. PubMed ID: 33550817
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.
Abonnenc M; Nabeebaccus AA; Mayr U; Barallobre-Barreiro J; Dong X; Cuello F; Sur S; Drozdov I; Langley SR; Lu R; Stathopoulou K; Didangelos A; Yin X; Zimmermann WH; Shah AM; Zampetaki A; Mayr M
Circ Res; 2013 Oct; 113(10):1138-47. PubMed ID: 24006456
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT.
Ghosh AK; Nagpal V; Covington JW; Michaels MA; Vaughan DE
Cell Signal; 2012 May; 24(5):1031-6. PubMed ID: 22245495
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-132 attenuated cardiac fibrosis in myocardial infarction-induced heart failure rats.
Wang G; Wang R; Ruan Z; Liu L; Li Y; Zhu L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32885809
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-328, a Potential Anti-Fibrotic Target in Cardiac Interstitial Fibrosis.
Du W; Liang H; Gao X; Li X; Zhang Y; Pan Z; Li C; Wang Y; Liu Y; Yuan W; Ma N; Chu W; Shan H; Lu Y
Cell Physiol Biochem; 2016; 39(3):827-36. PubMed ID: 27497782
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K/Akt signaling pathway via PIK3CA.
Yang X; Li X; Lin Q; Xu Q
Gene; 2019 Oct; 715():143995. PubMed ID: 31336140
[TBL] [Abstract][Full Text] [Related]
19. Microrna-139-5p inhibits epithelial-mesenchymal transition and fibrosis in post-menopausal women with interstitial cystitis by targeting LPAR4 via the PI3K/Akt signaling pathway.
Jiang C; Tong Z; Fang WL; Fu QB; Gu YJ; Lv TT; Liu DM; Xue W; Lv JW
J Cell Biochem; 2018 Aug; 119(8):6429-6441. PubMed ID: 29240250
[TBL] [Abstract][Full Text] [Related]
20. microRNA-29b Mediates the Antifibrotic Effect of Tanshinone IIA in Postinfarct Cardiac Remodeling.
Yang F; Li P; Li H; Shi Q; Li S; Zhao L
J Cardiovasc Pharmacol; 2015 May; 65(5):456-64. PubMed ID: 25636075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
